Health-related quality of life in patients receiving medicinal cannabis: systematic review and meta-analysis of primary research findings 2015-2025.

Health-related quality of life in patients receiving medicinal cannabis: systematic review and meta-analysis of primary research findings 2015-2025.

CED Clinical Relevance  #100High Clinical Relevance
Evidence Brief | CED ClinicSystematic review and meta-analysis finds medicinal cannabis associated with improved health-related quality of life across chronic conditions, with effects sustained over 12 months.
Quality Of LifeChronic ConditionsPatient OutcomesMeta-AnalysisMedicinal Cannabis

Health-related quality of life in patients receiving medicinal cannabis: systematic review and meta-analysis of primary research findings 2015-2025.

Systematic review and meta-analysis finds medicinal cannabis associated with improved health-related quality of life across chronic conditions, with effects sustained over 12 months.

What This Study Teaches Us

This meta-analysis provides the most comprehensive synthesis to date of quality of life outcomes following medicinal cannabis treatment across diverse chronic conditions. The sustained improvements over 12 months suggest that patient-reported benefits may persist with continued treatment, addressing a key gap in long-term outcome data.

Why This Matters

Quality of life is often the primary concern for patients with chronic conditions, yet it’s frequently overlooked in cannabis research focused on symptom-specific outcomes. This evidence supports quality of life as a legitimate treatment target and provides a framework for measuring this important patient-centered outcome in clinical practice.

Study Snapshot
Study Type Systematic Review and Meta-Analysis
Population Patients with chronic health conditions receiving medicinal cannabis, multiple studies from 2015-2025
Intervention Medicinal cannabis therapy
Comparator Pre-treatment baseline measures
Primary Outcome Health-related quality of life using validated measures
Key Finding Quality of life improvements observed across short-term, medium-term, and long-term follow-up periods
Journal Quality of Life Research
Year 2025
Clinical Bottom Line

Medicinal cannabis appears consistently associated with quality of life improvements across multiple chronic conditions and timeframes. These findings support incorporating validated quality of life measures into clinical assessments and suggest that patient reports of feeling ‘better overall’ may reflect measurable improvements in functional well-being.

What This Paper Does Not Show

The analysis cannot establish causation due to the predominantly observational nature of included studies and lack of placebo controls in most research. Specific mechanisms underlying quality of life improvements, optimal dosing strategies, or which patient populations benefit most remain undefined.

Where This Paper Deserves Skepticism

Pre-post comparisons without controls are vulnerable to placebo effects, regression to the mean, and natural disease fluctuations. The heterogeneity of conditions, cannabis formulations, and quality of life measures across studies may limit the generalizability of pooled effect estimates.

Dr. Caplan's Take
This confirms what I observe clinically – patients often report feeling ‘better overall’ even when specific symptoms show modest improvement. Having systematic evidence for quality of life benefits helps justify treatment decisions when targeting functional well-being rather than just symptom reduction. However, I remain cautious about the mostly uncontrolled nature of this evidence.
What a Careful Reader Should Take Away

Medicinal cannabis consistently associates with quality of life improvements across chronic conditions, providing evidence-based support for patient-reported functional benefits. However, the predominantly observational evidence base requires cautious interpretation, and individual patient responses will vary significantly.

Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan →

Want to discuss this topic with other patients and caregivers? Join the forum discussion →

FAQ

How significant were the quality of life improvements seen with medicinal cannabis?
The abstract doesn’t provide specific effect sizes, but improvements were consistent across short-term, medium-term, and long-term follow-up periods. The clinical significance would depend on the magnitude of change and the specific quality of life measures used.
Which chronic conditions showed the best quality of life responses to medicinal cannabis?
The abstract doesn’t break down results by specific conditions. The review included patients with various chronic health conditions, but condition-specific analyses aren’t detailed in this summary.
How long do quality of life benefits from medicinal cannabis typically last?
The analysis found sustained improvements over 12 months, suggesting durability of benefits with continued treatment. However, the specific trajectory of improvement and whether benefits plateau or continue isn’t detailed in the abstract.
Should quality of life measures be routinely used in medicinal cannabis treatment?
This evidence supports incorporating validated quality of life assessments into clinical practice, as they capture important patient-centered outcomes that may not be reflected in symptom-specific measures. Regular monitoring could help guide treatment decisions and demonstrate therapeutic value.

FAQ

Does medicinal cannabis improve quality of life in patients with chronic conditions?

Yes, this systematic review and meta-analysis found that medicinal cannabis is associated with improved health-related quality of life across various chronic health conditions. The improvements were observed across short-term (2 weeks to 3 months), medium-term (3-12 months), and long-term (โ‰ฅ12 months) treatment periods.

How long do the quality of life benefits of medicinal cannabis last?

The quality of life improvements associated with medicinal cannabis appear to be sustained over extended periods. This study found evidence of benefits maintained for 12 months or longer, suggesting the therapeutic effects are not just temporary improvements.

What types of chronic conditions were studied in this research?

The systematic review included studies examining medicinal cannabis treatment across various chronic health conditions that impact quality of life. The researchers used validated health-related quality of life measures to assess outcomes across this diverse range of conditions.

How reliable is the evidence for medicinal cannabis improving quality of life?

The evidence comes from a comprehensive systematic review and meta-analysis covering studies from 2015-2025, which represents the highest level of evidence synthesis. The researchers assessed risk of bias in randomized controlled trials and used validated quality of life measurement tools to ensure reliable findings.

When might patients expect to see quality of life improvements with medicinal cannabis?

Quality of life improvements can be observed as early as 2 weeks to 3 months after starting medicinal cannabis treatment. The study categorized benefits into short-term (2 weeks-3 months), medium-term (3-12 months), and long-term (โ‰ฅ12 months) periods, with positive effects seen across all timeframes.







Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.
Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance